IRVINE, Calif., Jan. 14, 2019 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the
world's leading temperature-controlled logistics company dedicated
to the life sciences industry, today announced it has partnered
with Dacos A/S ("Dacos"), a high-tech production company of life
sciences products with headquarters in Denmark, to deliver end-to-end
temperature-controlled logistics solutions to Dacos' global client
base of biopharmaceutical companies.
Dacos is a leading manufacturer of laboratory products for the
storage of biological commodities, including human and animal
cells, specializing in the production of high-quality cryogenic
vials, storage boxes, centrifuge tubes, shipment containers for
blood samples and PET bottles for serum and media. Partnering with
Cryoport will enable Dacos to offer Cryoport's full range of
temperature-controlled logistics solutions, including the Cryoport
Express® shippers, the industry-leading Cryoportal™
Logistics Management Platform, Smartpak II™ Condition Monitoring
System and 24/7/365 logistics support, to its existing client base
of biopharmaceutical companies.
Max Terpager, Chief Executive Officer at Dacos, said, "We have
clients all over the world and many of them require reliable,
secure logistics solutions for their temperature-sensitive
commodities, in order to minimize the risks of temperature
excursions that may impact the quality of their products. We
receive requests for these solutions on a daily basis, but until
now we have never had the correct solution to offer them.
Cryoport's full suite of logistics solutions, which encompasses
full Chain of Custody, Chain of Condition and Chain of Compliance™
traceability, offers a secure, temperature-controlled solution to
track and maintain the integrity of temperature-sensitive products.
We are pleased to now have the opportunity to fulfill the needs of
our client base by offering Cryoport's solution to ensure that
products are handled correctly during transportation, backed up by
data and non-stop monitoring, so that our clients can take a more
proactive approach to managing their supply chain."
Jerrell Shelton, Chief Executive
Officer of Cryoport, commented, "Dacos is a highly innovative,
reputable company with a global client base. Forming this
relationship with Dacos will give us the opportunity to provide
Dacos' clients with our sophisticated and proven
temperature-controlled logistics solutions at a time when the
global need for these solutions is rapidly growing. Our
unparalleled expertise in life sciences logistics allows
biopharmaceutical companies to rely on an intelligent,
technology-driven solution to mitigate supply chain risks. We see
the need for our solutions growing as the regenerative therapy
market continues to advance and higher numbers of samples are sent
around the world."
About Cryoport, Inc.
Cryoport is the life sciences industry's most trusted global
provider of temperature-controlled logistics solutions for
temperature-sensitive life sciences commodities, serving the
biopharmaceutical market with leading-edge logistics solutions for
biologic materials, such as regenerative medicine, including
immunotherapies, stem cells and CAR-T cells. Cryoport's solutions
are used by points-of-care, CRO's, central laboratories,
pharmaceutical companies, manufacturers, university researchers et
al; as well as the reproductive medicine market, primarily in IVF
and surrogacy; and the animal health market, primarily in the areas
of vaccines and reproduction. Cryoport's proprietary Cryoport
Express® Shippers, Cryoportal™ Logistics Management
Platform, leading-edge SmartPak II™ Condition Monitoring System and
geo-sensing technology, paired with unparalleled cold chain
logistics expertise and 24/7 client support, make Cryoport the
end-to-end cold chain logistics partner that the industry
trusts.
Cryoport is dedicated to: simplifying global cold chain
logistics through innovative technology, unmatched monitoring and
data capture and support, including consulting; delivering the most
advanced temperature-controlled logistics solutions for the life
sciences industry; and providing vital information that provides
peace of mind throughout the life of each logistics process.
For more information, visit www.cryoport.com. Sign up to follow
@cryoport on Twitter at www.twitter.com/cryoport.
Forward Looking Statements
Statements in
this news release which are not purely historical, including
statements regarding Cryoport, Inc.'s intentions, hopes, beliefs,
expectations, representations, projections, plans or predictions of
the future are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. It is important
to note that the Company's actual results could differ materially
from those in any such forward-looking statements. Factors that
could cause actual results to differ materially include, but are
not limited to, risks and uncertainties associated with the effect
of changing economic conditions, trends in the products markets,
variations in the Company's cash flow, market acceptance risks, and
technical development risks. The Company's business could be
affected by a number of other factors, including the risk factors
listed from time to time in the Company's SEC reports including,
but not limited to, the Company's 10-K for the year ended
December 31, 2017 filed with the SEC.
The Company cautions investors not to place undue reliance on the
forward-looking statements contained in this press release.
Cryoport, Inc. disclaims any obligation, and does not undertake to
update or revise any forward-looking statements in this press
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dacos-as-partners-with-cryoport-to-offer-full-suite-of-temperature-controlled-logistics-solutions-to-global-client-base-300777409.html
SOURCE Cryoport, Inc.